Iclaprim clinical trials
Also written MTF-100.
How each study uses iclaprim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses iclaprim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2CompletedPhase 3Motif BioNCT02607618Written as Iclaprim
- Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1CompletedPhase 3Motif BioNCT02600611Written as iclaprim
- Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated PneumoniaTerminatedPhase 2Arpida AGNCT00543608Written as iclaprim
- Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)CompletedPhase 3Arpida AGNCT00303550Written as Intravenous iclaprim
Codes
What other systems call iclaprim · ClinicalTrials.gg INT004647
- MeSH (NLM) C486448iclaprimConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 42445HUU0OICLAPRIMConfirmed FDA, NLM, Wikidata
- Wikidata Q907480iclaprimConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65877IclaprimOne source FDA
- DrugBank DB06358One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C486448 | iclaprim | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 42445HUU0O | ICLAPRIM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q907480 | iclaprim | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65877 | Iclaprim | One source FDA |
| DrugBank | DB06358 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.